| 08:00-09:00 |
Registration |
| 09:00-10:45 |
Session I: Food allergy
Chairs: Bernadette Eberlein (Germany), Alexandra Santos (United Kingdom)
| 09:00-09:25 |
Integrating BAT and CRD in food allergy, Peter Korosec (Slovenia) |
| 09:25-09:50 |
BAT results as predictors of clinical reactivity, Bernadette Eberlein (Germany) |
| 09:50-10:45 |
Oral presentations |
| 09:50-10:05 |
Correlation of in-vivo oral food challenge with in-vitro basophil activation test in hazelnut allergic patients |
| 10:05-10:20 |
The early decrease in basophil sensitivity is a biomarker of sustained unresponsiveness in peanut oral immunotherapy |
| 10:20-10:35 |
Blood stability in BAT Test |
|
| 10:45-11:15 |
Coffee break |
| 11:15-13:00 |
Session II: Drug hypersensitivity
Chairs: Cristobalina Mayorga (Spain), Anna Nopp Scherman (Sweden)
| 11:15-11:40 |
BAT in IgE-mediated and non IgE-mediated hypersensitivity, Cristobalina Mayorga (Spain) |
| 11:40-12:05 |
Expanding the use of BAT in immediate hypersensitivity, Vito Sabato (Belgium) |
| 12:05-13:00 |
Oral presentations |
| 11:50-12:05 |
Basophil Activation test is highly sensitive for the diagnosis of type I gelofusine allergy |
| 12:05-12:20 |
Drug allergy during pregnancy: A new aspect |
| 12:20-12:35 |
Monitoring hypersensitivity to a novel IgE immuno-therapy undergoing First-in-Class, First-in-Man clinical trial with the Basophil Activation Test |
| 12:35-12:50 |
Comparative analysis of basophil gating strategies for the Basophil Activation Test |
|
| 13:00-14:30 |
Lunch |
| 14:30-16:15 |
Session III: Future Developments
Chairs: Anna Nopp Scherman (Sweden), Edward Knol (The Netherlands)
| 14:30 – 14:55 |
Advantages and limitations of BAT, Anna Nopp Scherman (Sweden), |
| 14:55 – 15:20 |
Automated analysis of BAT, Paul Rozaire (France) |
| 15:20 – 16:15 |
Oral presentations |
| 15:10-15:25 |
An automated method for determining quality control. Parameters for basophil activation testing based on flow data |
| 15:25-15:40 |
Is intracellular histamine a more comprehensive marker for BAT? |
| 15:40-15:55 |
Feasability evaluation of automating and miniaturizing sasophil activation testing in 96 well plate format |
| 15:55-16:10 |
Validation experiments on Basophil Activation test using 96-Deep well microtiter plates with desktop flow cytometer detection |
|
| 16:15-16:55 |
Round table with discussion “External Quality Assurance of the Basophil Activation Test” |
| 16:55-17:00 |
End of meeting |
